DISADVANTAGES OF COCAINE AS A NEURONAL UPTAKE BLOCKING AGENT: COMPARISON WITH DESIPRAMINE IN GUINEA‐PIG RIGHT ATRIUM
- 1 March 1983
- journal article
- research article
- Published by Wiley in Journal of Autonomic Pharmacology
- Vol. 3 (2) , 61-71
- https://doi.org/10.1111/j.1474-8673.1983.tb00521.x
Abstract
1 Cocaine and desipramine (DMI) are widely used as neuronal uptake blocking agents in studies of cardiac sympathetic transmission in isolated tissue preparations. It is generally assumed that these pharmacological tools do not alter transmitter release or postjunctional effector response. To test this assumption, we have compared the effects of cocaine and DMI on rate responses to sympathetic nerve stimulation and exogenous noradrenaline in guinea-pig isolated right atria. 2 Right atria were equilibrated with the irreversible α-adrenoreceptor antagonist benextramine to prevent any effect of presynaptic α-adrenoreceptors. Cumulative (–) noradrenaline concentration-response curves were shifted to the left by DMI (0.01–1 μM) without significant change in the resting or maximum rates. Cocaine (1–100 μM) also caused sensitisation to noradrenaline but caused a biphasic change in resting atrial rate. In addition there was a small but significant depression of the maximum rate at cocaine 10 and 100 μM. 3 Sympathetic nerve stimulation was achieved by applying trains of 1, 2 and 4 electrical field pulses delivered during one atrial refractory period. DMI caused a concentration dependent potentiation of responses to field stimulation. Cocaine (1 μM) caused significant enhancement of peak responses to field stimulation but no further enhancement and indeed depressed peak responses were observed at cocaine 10 and 100 μM respectively. 4 The time for atrial period to return halfway to baseline after field stimulation (t 1/2) was enhanced by cocaine in a concentration dependent manner as was observed with DMI. 5. We conclude that cocaine (but not DMI) decreases the maximum response to exogenous noradrenaline (postjunctional depression). The reduction of the peak response to sympathetic nerve stimulation in the presence of cocaine to below control responses suggests that cocaine also depresses the release of transmitter. These additional depressant properties of cocaine, which occur in a concentration range of neuronal uptake block, are important disadvantages and should discorage its use in experiments on sympathetic transmission.This publication has 23 references indexed in Scilit:
- [3H]Desipramine and [3H]imipramine binding are not associated with noradrenaline and serotonin uptake in the brainEuropean Journal of Pharmacology, 1982
- High-affinity [3H]desipramine binding in the peripheral and central nervous system: A specific site associated with the neuronal uptake of noradrenalineEuropean Journal of Pharmacology, 1982
- EFFECT OF NORADRENALINE REUPTAKE BLOCKADE ON EVOKED TRITIUM OVERFLOW FROM MOUSE VASA DEFERENTIA AND RAT CORTEX SLICES PREVIOUSLY INCUBATED WITH3H-NORADRENALINEJournal of Autonomic Pharmacology, 1981
- Refractory period field stimulation of right atria: A method for studying presynaptic receptors in cardiac autonomie transmissionJournal of Pharmacological Methods, 1981
- A pharmacological method to estimate the pK I of competitive inhibitors of agonist uptake processes in isolated tissuesNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1981
- Evidence against presynaptic α-adrenoreceptor modulation of cardiac sympathetic transmissionNature, 1980
- The effects of cocaine, chlorpheniramine and tripelennamine on the cardiac responses to sympathetic nerve stimulationEuropean Journal of Pharmacology, 1980
- EFFECTS OF TRICYCLIC ANTIDEPRESSANTS ON UPTAKE AND RELEASE OF 3H-NORADRENALINE IN ISOLATED GUINEA-PIG ATRIAClinical and Experimental Pharmacology and Physiology, 1974
- RESTING AND STIMULATION-INDUCED EFFLUX OF TRITIUM FROM GUINEA-PIG ATRIA INCUBATED WITH 3H-NORADRENALINEClinical and Experimental Pharmacology and Physiology, 1974
- A kinetic analysis of drugs that inhibit the adrenergic neuronal membrane amine pumpBiochemical Pharmacology, 1967